Navigation Links
Biocell Center Corporation Partners with New England's Largest Community-Based Hospital Network to Offer a Unique Service in Amniotic Fluid Stem Cell Preservation
Date:3/8/2010

MEDFORD, Mass., March 8 /PRNewswire/ -- Biocell Center Corporation and Caritas Christi Health Care, New England's largest community-based hospital network, and its flagship hospital St. Elizabeth's Medical Center, are pleased to announce the launch of a cryopreservation service for amniotic fluid stem cells obtained during a routine second trimester amniocentesis procedure.

According to Dr. Lucy Bayer-Zwirello, Chief of Maternal Fetal Medicine at Caritas Christi and Associate Professor of Obstetrics and Gynecology at Tufts University School of Medicine, "Amniotic fluid is one of the richest sources of mesenchymal stem cells that are viewed by many as the next frontier in stem cell therapy, with dozens of studies in cellular therapies and tissue regeneration on-going."    

"We are proud of this very important collaboration," said Dr. Kate Torchilin, CEO of Biocell Center Corporation. "We are looking forward to working with such a prominent New England hospital group as Caritas Christi to bring to its patients the opportunity to cryopreserve the cells from amniotic fluid as a biological insurance for their children."  

"These cells are very young in their development and can become many different cells and tissue types, unlike more developed adult stem cells," Dr. Torchilin added. "Once properly cryopreserved, the amniotic fluid cells can be stored for decades, and from the small sample enough cells can be generated for a potential medical procedure for the child from birth well into adulthood, as well as for immediate family members if required."

Biocell Center has recently been featured in L'Osservatore Romano, the official newspaper of the Vatican, in an interview heralding amniotic fluid stem cells as "the future of medicine" and touting this source of stem cells as morally acceptable. Amniotic fluid stem cells can be easily harvested during amniocentesis, thus making them very easy for the doctor to collect.  

"We see this service as very valuable for our patients because it gives them a unique opportunity to preserve cells for their baby's future. And, as a doctor, I appreciate the ability to give that extra service and option to my patients without any changes to the standard clinical practice," said Dr. Bayer-Zwirello.  

Caritas Christi will be offering this service as part of the standard genetic amniocentesis procedure at all six of its hospitals across New England.

For additional information, please contact Laurie Fullerton, Public Relations Director at Biocell Center, at laurie.fullerton@biocellcenter.com, 781-391-2040, or Chris Murphy, Director of Media Relations, Caritas Christi, 617-562-5652, christopher.murphy@caritaschristi.org.

This release was issued through eReleases(TM).  For more information, visit http://www.ereleases.com.  

SOURCE Biocell Center Corporation

Back to top
'/>"/>
SOURCE Biocell Center Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Scientists Spot Brains Free Will Center
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
5. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
6. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
7. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
8. End-to-End HR Performance Benchmarks: Metrics That Will Help Turn the HR Cost Center into a Productivity Driver
9. Governor Rendell Proclaims Sept. 9-15 as Senior Community Center Week
10. Concentra Opens On-Site Medical Unit at World Trade Center Site
11. Workers Win Contract at St. Francis Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol ... is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex ... in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier this ... The former overall number one pick in the 2001 NFL Draft, to the Atlanta ... record for the most career rushing yards by a quarterback (6,109) and the most ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner ... Education Research Award. The award honors scholars exemplary in their capacity to communicate ... who has demonstrated the capacity to deepen the public’s understanding and appreciation of ...
(Date:4/24/2017)... ... April 24, 2017 , ... Sean Fay is the undisputed ... Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold more than 100 ... in the last 25 years. , Now, due to changes in the broadcast media ...
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers ... to bring their novel lifesaving device for the everyday use of parents worldwide. ... specially designed to read a child’s vital signs, and detect unusual symptoms or ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... 2017 Halo Labs announces the launch of ... system called the Horizon at PEGS 2017 in ... system analyzes sub visible particulate matter in biopharmaceutical samples ... as early as candidate selection and pre-formulation. ... research organization Elion Labs for system validation. ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
Breaking Medicine Technology: